Endocrine and anti-tumour effects in breast cancer patients treated neo-adjuvantly with the aromatase inhibitor, letrozole

被引：0
|
作者：
Miller, WR [1 ]
Dixon, JM [1 ]
Telford, J [1 ]
Marson, L [1 ]
Bellamy, C [1 ]
Kurian, K [1 ]
MacFarlane, L [1 ]
Anderson, TJ [1 ]
机构：
[1] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P304
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [21] Anti-tumour effects of a dual cancer-specific oncolytic adenovirus on Breast Cancer Stem cells
    Li, Wenjie
    Li, Yiquan
    Cui, Yingli
    Li, Shanzhi
    Zhu, Yilong
    Shang, Chao
    Song, Gaojie
    Liu, Zirui
    Xiu, Zhiru
    Cong, Jianan
    Li, Tingyu
    Li, Xiao
    Sun, Lili
    Jin, Ningyi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (02) : 666 - 676
  • [22] Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: A comparative endocrine study
    Celio, L
    Martinetti, A
    Ferrari, L
    Buzzoni, R
    Mariani, L
    Miceli, R
    Seregni, E
    Procopio, G
    Cassata, A
    Bombardieri, E
    Bajetta, E
    ANTICANCER RESEARCH, 1999, 19 (3B) : 2261 - 2268
  • [23] Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer
    Núñez, NP
    Jelovac, D
    Macedo, L
    Berrigan, D
    Perkins, SN
    Hursting, SD
    Barrett, JC
    Brodie, A
    CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5375 - 5380
  • [24] Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
    H L Neville-Webbe
    R E Coleman
    I Holen
    British Journal of Cancer, 2010, 102 : 1010 - 1017
  • [25] Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
    Neville-Webbe, H. L.
    Coleman, R. E.
    Holen, I.
    BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 1010 - 1017
  • [26] Phase II trial of letrozole (a novel oral nonsteroidal aromatase inhibitor) in postmenopausal patients with advanced or recurrent breast cancer
    Tominaga, T
    Ohashi, Y
    Abe, R
    Yoshida, M
    Koyama, H
    Nomura, Y
    Bhatnagar, AS
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 373 - 373
  • [27] The Effects Of Baduanjin On Menopausal Symptoms In Patients With Breast Cancer Treated With Aromatase Inhibitors
    Hou, Xiaohui
    Lan, Hao
    Liao, Jingwen
    Hu, Min
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 1083 - 1083
  • [28] EFFECTS OF ANAT BANIEL METHOD® NEUROMOVEMENT® LESSONS ON WOMEN WITH BREAST CANCER TREATED WITH AN AROMATASE INHIBITOR
    Pederson, Julie
    Hunt, Sheila
    Hollingsworth, Tyler
    Cisneros, Tracy
    Rivers, Shelby
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [29] Single cell characterization of longitudinal biopsies from breast cancer patients treated with the aromatase inhibitors letrozole and exemestane in sequence
    Ghannoum, Salim
    Steen, Chloe
    Fongard, Marie
    Bjornstad, Marius
    Reitsma, Laurens
    Geisler, Stephanie
    Seyedzadeh, Manouchehr
    Buvarp, Unn-Cathrin
    Loeng, Marie
    Luders, Torben
    Lambrechts, Diether
    Lyngra, Marianne
    Kristensen, Vessela
    Geisler, Jurgen
    Tekpli, Xavier
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor
    Salman, Tarik
    Demir, Leyla
    Varol, Umut
    Akyol, Murat
    Oflazoglu, Utku
    Yildiz, Yasar
    Taskaynatan, Halil
    Cengiz, Hakan
    Guvendi, Guven
    Kucukzeybek, Yuksel
    Alacacioglu, Ahmet
    Tarhan, Oktay
    JOURNAL OF BUON, 2016, 21 (06): : 1419 - 1424
12345